ArchiveSjögren's syndrome (SS) is an autoimmune disease involving exocrine glands of the whole body. It is characterized by the infiltration of lymphocytes into exocrine glands such as salivary glands and lacrimal glands, resulting in insufficient secretion of the glands. The clinical manifestations are mainly dry mouth and dry eyes, and can also invade the respiratory system and digestive system, thus affecting the quality of life of patients and even life-threatening. The pathogenesis of SS is not yet clear. At present, symptomatic treatment is the main treatment. This article reviewed related drugs in recent years, aiming to provide some reference for clinical practice.
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by multiple joint destruction, and in severe cases, there may be irreversible joint destruction and even systemic organ involvement. The therapeutic targets of RA have been constantly explored and updated. This article reviewed the new progress of biologics and targeted drugs for RA, to provide certain reference for clinical drug use.
To investigate the effects of erianin on renal fibrosis in diabetic nephropathy (DN) rats and its regulatory mechanism.
All male SD rats were divided into control group, model group, dexamethasone group, vertepofin group, low-dose erianin group, high-dose erianin group and erianin combined with dexamethasone group, with 10 rats in each group. The levels of microalbuminuria (MAU) and renal function were detected. The renal tissue pathological changes and collagen fibers deposition were observed. The levels of malondialdehyde (MDA) and superoxide dismutase (SOD) in renal tissue were detected. Real-time quantitative polymerase chain reaction was used to detect tumor necrosis factor (TNF)-α, interleukin (IL)-1β and transforming growth factor (TGF)-β1 mRNA level. Western blotting was used to detect the Yes-associated protein (YAP)/transcriptional co-activator with PDZ-binding motif (TZA), connective tissue growth factor (CTGF), fibronectin (FN), and plasminogen activator inhibitor-1 (PAI-1) protein expression.
Compared with the control group, MAU, serum creatinine (Scr), blood urea nitrogen (BUN), propylene diol content, messenger (m) RNA levels of TNF-α, IL-1β, TGF-β1 and protein expression of YAP, TAZ, CTGF, FN, PAI-1 in model group and dexamethasone group were increased, while SOD activity was decreased (P<0.05). Compared with model group, MAU, Scr, BUN, propanediol content, mRNA levels of TNF-α, IL-1β, TGF-β1 and protein expression of YAP, TAZ, CTGF, FN and PAI-1 in vertepofin group and erianin group were decreased, while SOD activity was increased (P<0.05). After dexamethasone was added in the supplement experiment, the protective effect of high dose of erianin on DN rats was reversed (P<0.05).
Erianin can alleviate renal fibrosis in DN rats by inhibiting YAP/TAZ signaling pathway.
To investigate the therapeutic effect of compound Shougong power combined with zoledronic acid on bone metastasis of lung cancer, and the effect on B lymphocyte induced maturation protein (Blimp)1/B cell lymphoma factor (Bcl)-6 pathway.
The mouse model of lung cancer bone metastasis was established and divided into bone metastasis group, low dose of traditional Chinese medicine (40 mg/kg compound Shougong powder) group, high dose of traditional Chinese medicine (120 mg/kg compound Shougong powder) group, western medicine (50 μg/kg zoledronic acid) group and combined treatment (120 mg/kg compound Shougong powder+50 μg/kg zoledronic acid) group, and set up sham operation group, with 10 mice in each group. After 21 days, tibial injury, pathological morphology, number of osteoclasts, in vivo imaging system fluorescence signal of bone metastasis and expression levels of Blimp1 and Bcl6 in tibial tissue were observed.
Compared with the sham operation group, the number of osteoclasts, tumor cell fluorescence signals and Blimp1 expression in bone metastasis group were increased, while the Bcl-6 expression decreased (P<0.01). Compared with the bone metastasis group, the number of osteoclasts, tumor cell fluorescence signal and Blinp1 expression in the low and high dose traditional Chinese medicine groups and the western medicine group decreased, while Bcl-6 expression increased (P<0.01). Combination therapy enhanced the therapeutic effect of bone metastasis in lung cancer (P<0.01).
The combination of compound Shougong powder and zoledronic acid has a synergistic effect in the treatment of lung cancer bone metastasis, which may be related to the inhibition of the Blinmp1/Bcl-6 pathway.
To investigate the effects of cisatracurium on proliferation and apoptosis of human osteosarcoma cell Saos-2 and its possible mechanism.
Saos-2 cells were cultured in vitro and randomly divided into control group, cisatracurium low, medium and high dose groups. Real time quantitative polymerase chain reaction was used to detect the expression of micro RNA (miR)-505. MTT, plate clone formation experiment and flow cytometry were used to detect cell proliferation, clone formation and apoptosis, respectively.
Compared with the control group, the cell proliferation inhibition rate, apoptosis rate and miR-505 expression were increased in cisatracurium low, medium and high dose groups, and the number of clone formation was decreased in a dose-dependent manner (P<0.05). After transfection of miR-505 mimics, the cell proliferation inhibition rate and apoptosis rate increased, and the number of clone formation was decreased (P<0.05). After transfection of miR-505 inhibitor combined with cisatracurium, the cell proliferation inhibition rate and apoptosis rate decreased, and the number of clone formation was increased (P<0.05).
Cisatracurium can inhibit the proliferation and cloning of Saos-2 cells and promote apoptosis by up-regulating the expression of miR-505.
To investigate the effects of Stanozolol on amino acid neurotransmitters and growth hormone (GH)/insulin-like growth factor-1 (IGF-1) in growth hormone deficiency mice.
Fifty-four mice were randomly divided into healthy group (group A), model group (group B), low-dose Stanozolol group (group C), medium-dose Stanozolol group (group D), high-dose Stanozolol group (group E), and prednisone acetate group (group F), with 9 mice in each group. During the administration period, body weight gain of mice was calculated. The levels of amino acid neurotransmitters glutamic acid (Glu) and γ-aminobutyric acid (GABA) in serum, as well as GH levels were determined by enzyme-linked immunosorbent assay. Hematoxylin-eosin staining was used to observe the histomorphology of tibia. Immunoblotting and polymerase chain reaction were used to detect the expressions of IGF-1 and GH in hippocampus tissue.
Compared with group A, rats in group B had decreased body weight, serum GABA and GH levels, and IGF-1, GH mRNA, and protein expression levels in hippocampus tissue, while serum Glu level was increased (P<0.01). Compared with group B, rats in group C had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). Compared with group C, rats in group D had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). Compared with group D, rats in group E had increased body weight, serum GABA and GH levels, and IGF-1 and GH expressions in hippocampus tissue, while serum Glu level was decreased (P<0.01). There were no differences in body weight, serum GABA, Glu, GH, and IGF-1 and GH expressions in hippocampus tissue between group E and group F (P>0.05).
Stazolol can regulate amino acid neurotransmitters in GHD mice, down-regulate Glu content, increase GABA content and promote the expression of endocrine GH/IGF-1 signaling pathway, which provides a new idea for GHD treatment.
To observe the effects of baritinib on haemoglobin (Hb) levels in patients with rheumatoid arthritis (RA) with moderate to high disease activity.
RA patients receiving biologics or targeted synthetic drugs admitted to the Department of Arthropathy of Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine from September 2021 to May 2023 were retrospectively included. During the study, 60 patients were enrolled in the baritinib group, and the tumor necrosis factor inhibitor (TNFi) group was matched by random selection at the ratio of 1:1, so 60 patients in each group. The clinical information of all patients at baseline and 12-week follow-up period were collected, and the changes of Hb levels were monitored.
After treatment, 42 patients in TNFi group and 45 patients in baritinib group reached the therapeutic effect standard, and there was no statistical significance between the two groups (P>0.05). After 12 weeks of treatment, Hb level in bariatinib group was higher than that before treatment, and there was no significant difference between responders and non-responders (P>0.05). After treatment, Hb level in patients with anemia at baseline increased by 8.21 g/L, while that in those without anemia increased by 0.66 g/L, with statistical significance (P<0.05).
The efficacy of baritinib in the treatment of moderate to high disease activity RA is comparable to that of TNFi. Baritinib can improve anemia in RA patients by reducing inflammation, and Hb levels in patients with baseline anemia increased significantly after 12 weeks of treatment, and the extent of increase was significantly higher than that in patients without baseline anemia.
To investigate the effects of Xuesuisheng granule combined with cyclosporine (Cs) A on non-severe aplastic anemia (NSAA) and its effects on GATA binding protein (GATA)-3, granulocyte colony stimulating factor (G-CSF) and early hematopoietic recovery.
Forty-six patients with NSAA admitted to our hospital from June 2021 to January 2023 were selected and divided into observation group (n=24) and control group (n=22) by random number table. The control group was treated with CsA, and the observation group was treated with Xuesuisheng granules. The clinical efficacy, changes in GATA-3, G-CSF, hemoglobin (Hb), red blood cells (RBC), hematocrit (HCT), cellular immune function and the occurrence of adverse reactions were compared between the two groups.
The total effective rate of the observation group was higher than that of the control group, but the difference was not statistically significant (54.55% vs 75.00%, P>0.05). Compared with the control group, the levels of GATA-3, cluster of differentiation CD4+ and CD4+/CD8+ in the observation group were decreased (P<0.05), while the levels of G-CSF, Hb, RBC, HCT and CD8+ were increased (P<0.05). The adverse reactions in the observation group were less than those in the control group, but the difference was not statistically significant (36.36% vs 25.00%, P>0.05).
Xuesuisheng granule combined with CsA can improve GATA-3, G-CSF and early hematopoiesis in patients with NSAA to a certain extent.
To observe the efficacy and safety of Pudilan Xiaoyan oral liquid in the treatment of moderate acne vulgaris with dampness and heat.
A total of 210 cases of moderate acne vulgaris were collected according to the principles of multi-center, randomized, double-blind single simulation and placebo parallel control. Among them, 105 cases in the experimental group were treated with Pudilan anti-inflammatory oral liquid+clindamycin gel, the control group (105 patients) were treated with Pudilan Xiaoyan oral liquid simulator+clindamycin gel for 4 weeks. The clinical efficacy was evaluated after the treatment.
The effective rate of the experimental group was 86.54%, and the recovery rate was 4.81%, while the effective rate of the control group was 35.92%, and the recovery rate was 0.00%, and the difference was statistically significant (P<0.05). The total number of skin lesions and the improvement of papules and pustules in experimental group were significantly better than those in the control group, with statistical significance (P<0.05). The experimental group was better than the control group in improving the tongue coating and constipation, and the difference was statistically significant (P<0.05). In terms of safety, no adverse reactions were observed in the experimental group and the control group.
Pudilan Xiaoyan oral liquid in the treatment of moderate acne vulgaris of damp-heat type has obvious curative effect, quick effect and small adverse reaction.
To evaluate the clinical efficacy and safety of "medicine-bath-ointment" therapy in the treatment of blood heat syndrome of plaque psoriasis.
A total of 77 patients were randomly divided into experiment group (n=39) and control group (n=38). Both groups were given Niu 1 decoction, while the experiment group was treated with Xiaoyin No.1 decoction medicinal bath. The clinical efficacy and psoriasis area and severity index (PASI) of the two groups before and after treatment were observed, and the adverse reactions and recurrence rates were analyzed.
The total effective rate of treatment in the experimental group is higher than that in the control group (92.31% vs 78.94%, P<0.05). After treatment, the total PASI scores of both groups were lower than before treatment, and the infiltration and desquamation indices of the experimental group decreased, the differences were statistically significant (P<0.05). There was no statistically significant difference in recurrence rates between the two groups (7.69% vs 7.89%, P=0.923). There were no significant adverse reactions in the both groups.
"Medicine-bath-ointment" therapy has good clinical efficacy and safety in the treatment of plaque psoriasis with blood heat syndrome.
To establish an evaluation index system for the rational use of drugs in the treatment of multiple myeloma (MM).
A total of 30 experts were selected for two rounds of expert consultation by Delphi method. The opinions of experts were collected and the results were statistically analyzed. The basic information and questionnaire results of the questioned experts were analyzed, and the positive coefficient, average score, full score ratio, coefficient of variation and weight value were calculated.
The evaluation indexes of rational use of MM drugs included 6 primary indexes and 36 secondary indexes. The effective recovery rate of the expert questionnaire was 100%, the authority coefficient was 0.86, and the coordination coefficient was 0.293, which had statistical significance (P<0.001).
The experts are highly motivated, authoritative and coordinated, and the evaluation system of MM is objective and reasonable, which can provide quantifiable evaluation for MM drug selection.
To explore the clinical efficacy and safety of Yishen granule combined with warm acupuncture and moxibustion in the treatment of myelosuppression after chemotherapy of lung cancer.
A total of 66 lung cancer patients with post-chemotherapy myelosuppression admitted to the department of oncology, Yueyang Hospital of Integrated Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine from July 1, 2019 to August 31, 2022 were included and randomly divided into control group and experiment group, with 33 cases in each group. The control group was treated with Yishen granules orally, and the experiment group was treated with Yishen granules combined with warm acupuncture. The changes of bone marrow suppression indexes, including white blood cell count, neutrophil count, hemoglobin count and platelet count, were observed before treatment, 7 and 14 days after treatment. The European Organization for Research and Treatment of Cancer Quality of Life Scale was used to assess the quality of life of patients.
Compared with before treatment, myelosuppression indexes in both groups were significantly improved after 7 and 14 days of treatment, and the differences were statistically significant (P<0.05). After 14 days of treatment, the leukocyte count of the experiment group was significantly higher than that of the control group [(4.92±1.38)×109/L vs (4.13±1.62)×109/L, (P<0.05)]. The improvement of emotional function, total health status, fatigue and loss of appetite in experiment group was better than that in control group (P<0.05).
Yishen granule combined with warm acupuncture and moxibustion can effectively treat myelosuppression after chemotherapy for lung cancer, and the effect is slightly better than that of Yishen granule alone.
To study the relationship between traditional Chinese medicine (TCM) syndromes of diabetes mellitus type 2 (T2DM) and free fatty acid (FFA), tumor necrosis factor (TNF)-α and vascular endothelial growth factor (VEGF), and summarize the relationship between laboratory indexes and TCM syndrome types of T2DM.
A total of 300 patients with T2DM were collected from the outpatient and inpatient department of endocrinology of LongHua hospital affiliated to Shanghai university of TCM from January 2019 to March 2020, including 65 cases of Qi and Yin deficiency syndrome, 65 cases of damp heat trapped spleen syndrome, 50 cases of Yin deficiency and heat excess syndrome, 55 cases of Yin and Yang deficiency syndrome, and 65 cases of blood stasis venation syndrome. The relationship between each syndrome group and FFA, TNF-α and VEGF was measured and observed.
TNF-α in blood stasis venation syndrome group was significantly higher than those of Qi and Yin deficiency syndrome group, damp heat trapped spleen syndrome group, Yin deficiency and heat excess syndrome group and Yin and Yang deficiency syndrome group (P<0.05). The levels of VEGF in damp heat trapped spleen syndrome group and blood stasis venation syndrome group were significantly higher than those in Qi and Yin deficiency syndrome group, Yin and Yang deficiency syndrome group and Yin deficiency and heat excess syndrome group (P<0.05). The level of FFA in blood stasis venation syndrome group was higher than those in Qi and Yin deficiency syndrome group and Yin and Yang deficiency syndrome group, and the difference were statistically significant (P<0.05).
FFA, TNF- α and VEGF are closely related to blood stasis venation syndrome and damp heat trapped spleen syndrome of T2DM, but they are not sensitive indexes for early diagnosis of syndrome types of T2DM related complications.
Sotagliflozin is a drug with dual inhibitory effects on sodium-dependent glucose transporters (SGLT) 1 and 2. Inhibition of SGLT1 can inhibit glucose and galactose absorption in the digestive tract, and inhibition of SLGT2 can reduce glucose reabsorption in the renal tubules. Sotagliflozin has been shown to be effective in the treatment of type 2 diabetes mellitus. In recent years, it has shown great potential in cardiovascular diseases. Soglitazone can reduce adverse cardiovascular events in type 2 diabetes patients with cardiovascular risk factors. This article summarized the research on the application of sotagliflozin in diabetes mellitus complicated with cardiovascular diseases at home and abroad in recent years, in order to provide guidance for the further application of sotagliflozin in cardiovascular diseases.
Polyinosinic polycytidylic acid is an artificially synthesized double stranded ribonucleic acid that is recognized by Toll-like receptor 3, induces innate and adaptive immune responses. It is generally considered as a type Ⅰinterferon inducer, antiviral and anti-tumor immunomodulator agent, and also an effective vaccine adjuvant, and has shown great potential in the treatment of diseases. Therefore, this article reviewed the regulatory mechanism, safety, and the research progress of polyinosinic polycytidylic acid as an immunologic agent in clinical practice, hoping to provide useful reference for the follow-up research of polyinosinic polycytidylic acid.
B cell lymphoma (Bcl)-2 gene is mainly expressed in the outer mitochondrial membrane. It is the major regulator in the apoptotic signaling pathway, and its aberrant expression is closely related to tumor development. Bcl-2 protein, encoded by Bcl-2 gene, regulates apoptosis through protein-protein interactions and has become an important target for the treatment of chronic lymphocytic leukemia (CLL). Most of the Bcl-2 inhibitors are small molecule compounds. Fragment-based drug design approaches that mimic the BH3 structural domain of the Bcl-2 protein have driven the development of Bcl-2 inhibitors. The currently marketed Bcl-2-targeted inhibitor drug venetoclax can effectively treat CLL and small lymphocytic leukemia, and shows better clinical efficacy in B-lymphocyte malignancies, and other Bcl-2 inhibitor drugs that have entered clinical studies also show better development prospects. This article reviewed the mechanism of Bcl-2, and summarized the research progress of Bcl-2 inhibitors in recent years, to provide insights for the further development of Bcl-2 inhibitors.
Epileptic seizure induced by antipsychotic drugs is a problem that needs attention in clinical use. Current evidence shows that the risk of seizure induced by first-generation antipsychotics is low, except chlorpromazine. Among second-generation antipsychotics, clozapine has the highest risk of seizure induction, while olanzapine, risperidone, quetiapine, ziprasidone, and aripiprazole have a lower risk. Many factors influence the threshold of antipsychotic-induced seizures, such as seizure history, concomitant use of other drugs that lower the seizure threshold, comorbidity with other chronic diseases (e.g. organic brain diseases), individual susceptibility, and age, among which the antipsychotic blood concentration being most closely associated with increased seizure frequency. To reduce the risk of seizures, antipsychotic drugs should be slowly titrated from a small dose during the initial treatment stage, monitor blood drug concentrations, and maintain the minimum effective dose. Electroencephalogram changes may accompany the administration of antipsychotic medications, but the relationship between the abnormal rate of electroencephalogram and seizure risk is not clear. It is important to note that although there is substantial evidence that antipsychotics can lower seizure thresholds, some antipsychotics can also exert antiepileptic effects. Therefore, this article reviewed previous literature to explore the relationship between antipsychotics and seizures.
Chronic heart failure (CHF) has a long course and repeated symptoms, which not only leads to poor quality of life, but also causes serious economic burden to society. There is a remarkable effect of traditional Chinese medicine (TCM) in the treatment of CHF. Professor Zhou Duan, a famous TCM doctor in Shanghai, a lifetime professor in Longhua Hospital affiliated to Shanghai University of TCM, has been engaged in clinical and scientific research on the prevention and treatment of cardiovascular diseases with TCM. Professor Zhou Duan believes that on the premise of distinguishing different phases of the disease, the treatment of CHF should replenish Qi and invigorate blood, promote diuresis, nourish Yin, treat heart lung and kidney at the same time, protect the function of the spleen and stomach and take care of other illness as well. This article briefly reviewed relevant content for reference in clinical application.